Preparation method of C, O-spiro aryl glycoside compound

By optimizing the preparation method of C,O-spirocyclic aryl glycoside compounds, the problems of complicated steps and easy destruction of the screw ring structure in the prior art are solved, the yield and purity of compound A are improved, and a more efficient preparation process is achieved. .

CN119080853APending Publication Date: 2024-12-06JIANGSU LIANHUAN PHARMA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411456905.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-18
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

The existing preparation methods for C,O-spirocyclic aryl glycoside compounds are complicated, the overall yield is low, and the sensitive structure of the spirocyclic ring is easily destroyed, resulting in an increase in impurities, affecting product purity.

Method used

A new preparation method is adopted to reduce the damage of the helical ring structure by optimizing the reaction conditions and steps, and improve the yield and purity of compound A.

Benefits of technology

The total yield and purity of compound A are improved, the generation of impurities is reduced, and a more efficient preparation process is achieved.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_3
    Figure SMS_3
  • Figure SMS_4
    Figure SMS_4
Patent Text Reader

Abstract

The invention relates to the technical field of drug synthesis, and discloses a preparation method of a C, O-spiro aryl glycoside compound, which comprises the following steps: step 1, hydroxyl protection reaction: reacting a compound 14 with methoxy propylene under acid catalysis to generate a compound 15; step 2, debenzylation reaction: removing three benzyls from the compound 16 to generate a compound 17; step 3, performing protection reaction on hydroxyl groups, namely reacting three hydroxyl groups on the compound 17 with trimethylchlorosilane under an alkaline condition to generate a compound 18; step 4, splicing reaction: splicing the compound 15 and the compound 18 to generate a compound 19; and step five, cyclization reaction: performing cyclization on the compound 19 under the action of an acid catalyst to generate a target compound.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of drug synthesis, in particular to a method for preparing a class of C, O-spirocyclic aryl glycoside compounds. Background Art

[0002] As a new target for hypoglycemic drugs, SGLT-2 selective inhibitors are specifically distributed in the kidneys and have no significant effects on other tissues and organs. Diabetic patients with insulin resistance can still benefit from them. They are not prone to hypoglycemia and do not increase the weight of diabetic patients. SGLT-2 inhibitors have become a new research hotspot at home and abroad. The first SGLT-2 inhibitor discovered was the natural product phlorizin, but it was easily hydrolyzed into glycosides and phlorizin by glycosidases in the body, and had poor selectivity for SGLT-1 and SGLT-2 and large adverse reactions, so it did not become a treatment for diabetes. Currently, there are 6 SGLT-2 inhibitors on the market worldwide, namely: Canagliflozin, Dapagliflozin, Empagliflozin, Ipragliflozin, Luseogliflozin and Tofogliflozin. Among them, dapagliflozin has been approved for marketing in China.

[0003] CN 107709332 B reports a C, O-spirocyclic aromatic glycoside compound and its preparation and potential application in treating diabetes. The compound has the following general formula:

[0004] Patent CN 107709332 B briefly describes the preparation method of the compound represented by general formula I, and the preparation method is carried out according to the following scheme 1: Scenario 1: ,

[0005] From the above preparation scheme, it can be seen that using compounds 1 and 7 as starting materials, compound A is prepared through 12 steps, the route is lengthy, and the total yield is particularly low. In particular, the spiro ring in the target compound A is relatively sensitive. In scheme 1, the four steps of l, m, n, and o will destroy the spiro ring structure, resulting in an increase in impurities and a decrease in yield. Summary of the invention

[0006]

[0007]

[0008]

[0009]

[0010]

[0011]

[0012]

[0013]

[0014]

[0015]

[0016]

[0017]

[0018]

[0019]

[0020]

[0021]

[0022]

[0023]

[0024]

[0025]

[0026]

[0027]

[0028]

[0029]

[0030]

[0031]

[0032]

[0033]

[0034]

[0035]

[0036] , , , , , , , , , , , , , , , , , , , , , , , , .

[0037] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.

Claims

1. A method for preparing a C, O-spirocyclic aromatic glycoside compound, characterized in that: The preparation method uses compounds 14 and 16 as starting materials and prepares the compound through reaction, comprising the following steps: Step 1: hydroxyl protection reaction: compound 14 reacts with methoxypropylene under acid catalysis to generate compound 15; Step 2: debenzylation reaction, compound 16 removes three benzyl groups to generate compound 17; Step 3: hydroxyl protection reaction: the three hydroxyl groups on compound 17 react with trimethylsilyl chloride under alkaline conditions to generate compound 18; Step 4: splicing reaction, compound 15 and compound 18 are spliced ​​to generate compound 19; Step 5: cyclization reaction: Compound 19 undergoes ring closure under the action of an acidic catalyst to generate the target compound; The preparation method of compound 14 is: S1, esterification reaction, compound 20 selectively reacts with methanol to generate compound 21; S2, bromination reaction, compound 21 is brominated to generate compound 22; S3, diazo substitution reaction, compound 22 is diazo substituted to generate compound 23; S4, Friedel-Crafts acylation reaction, compound 23 reacts with an aromatic compound to generate compound 24; S5, reduction reaction, carbonyl reduction of compound 24 to generate key starting material compound 14; ; The preparation method of compound 16 is: SS1, hydroxyl protection reaction, compound 25 reacts with tert-butyldimethylsilyl chloride under alkaline conditions to generate compound 26; SS2, hydroxyl protection reaction, compound 26 reacts with halogenated benzyl to generate compound 27; SS3, hydroxyl deprotection reaction, compound 27 removes tert-butyldimethylsilyl to generate compound 28; SS4, halogenation reaction, compound 28 undergoes iodination reaction to generate compound 29; SS5, dehalogenation reaction, compound 29 is deiodinated to generate compound 30; SS6, demethylation reaction, compound 30 removes the methyl group to generate compound 31; SS7, oxidation reaction, compound 31 is oxidized to generate the key starting material compound 16; 。 2. The method for preparing a C, O-spirocyclic aromatic glycoside compound according to claim 1, characterized in that: In the step 1, the acid catalyst is p-toluenesulfonic acid, methanesulfonic acid, trifluoromethanesulfonic acid, hydrochloric acid, sulfuric acid or nitric acid; the solvent is tetrahydrofuran, dichloromethane, toluene, 2-methyltetrahydrofuran or acetonitrile; the molar ratio of the compound 14 to the acid catalyst is 1:0.01-0.2; the molar ratio of the compound 14 to 2-methoxypropylene is 1:1-15; the reaction temperature is -30-30°C; the reaction time is 0.2-12 hours; and the volume V / W of the reaction solvent is 5-20 times.

3. The method for preparing a C, O-spirocyclic aromatic glycoside compound according to claim 2, characterized in that: The debenzylation combination in step 2 is 5% palladium carbon / hydrogen, 10% palladium carbon / hydrogen, N-bromosuccinimide / ultraviolet light / calcium carbonate / carbon tetrachloride, N-iodosuccinimide / ultraviolet light / acetonitrile, 2,3-dichloro-5,6-dicyanobenzoquinone, boron trichloride / zinc chloride; the solvent is ethyl acetate, tert-butyl acetate, dichloromethane, toluene, tetrahydrofuran, 2-methyltetrahydrofuran, diformamide or N-methylpyrrolidone, the molar ratio of the compound 16 to the palladium catalyst is 1:0.05-0.2; the reaction temperature is 20-80°C; the reaction time is 4-24 hours; the volume V / W of the reaction solvent is 5-20 times.

4. The method for preparing a C, O-spirocyclic aromatic glycoside compound according to claim 3, characterized in that: The base in step three is morpholine, N-methylmorpholine, imidazole, triethylamine, diisopropylamine, sodium carbonate, sodium bicarbonate, potassium carbonate, potassium bicarbonate or sodium hydrogen or lithium diisopropylamide; the solvent is tetrahydrofuran, 2-methyltetrahydrofuran, toluene, acetonitrile, diformamide, N-methylpyrrolidone, dimethyl sulfoxide, the molar ratio of compound 17 to trimethylchlorosilane is 1:3~8; the reaction temperature is -20-10°C; the reaction time is 0.2-12 hours; the volume V / W of the reaction solvent is 5~20 times.

5. The method for preparing a C, O-spirocyclic aromatic glycoside compound according to claim 4, characterized in that: In the step 4, the splicing reaction reagent is isopropyl magnesium chloride, methyl magnesium chloride, ethyl magnesium chloride, isopropyl magnesium bromide, methyl magnesium bromide, ethyl magnesium bromide, n-butyl lithium, tert-butyl lithium or isopropyl magnesium chloride lithium chloride; the solvent is tetrahydrofuran, 2-methyltetrahydrofuran, toluene, acetonitrile; the reaction temperature is -90-0°C, the molar ratio of compound 15 to compound 18 is 1:1.1-2.0; the reaction temperature is preferably -90-0°C; the reaction time is preferably 0.2-12 hours; the reaction solvent is used in an amount V / W of 5 to 20 times.

6. The method for preparing a C, O-spirocyclic aromatic glycoside compound according to claim 5, characterized in that: In the step 5, the acidic catalyst is p-toluenesulfonic acid, methanesulfonic acid, trifluoromethanesulfonic acid, hydrochloric acid, sulfuric acid and nitric acid; the solvent is tetrahydrofuran, 2-methyltetrahydrofuran, toluene, dichloromethane, methanol, ethanol or isopropanol; the reaction temperature is 15-60°C, the molar ratio of the compound 19 to the acid catalyst is 1:0.01~0.5; the reaction temperature is 15-60°C; the reaction time is 2-24 hours; the volume V / W of the reaction solvent is 5~20 times.

7. The method for preparing a C, O-spirocyclic aromatic glycoside compound according to claim 1, characterized in that: In the compound 23, R1 is selected from: hydrogen, halogen, or a substituted or unsubstituted group selected from the following group: C1-C6 alkyl, C2-C6 alkenyl, C1-C6 alkoxy, C2-C6 alkynyl, C3-C10 cycloalkyl, C3-C10 cycloalkenyl, C2-10 alkoxycarbonyl, C3-12 cycloalkyl, heteroC3-12 cycloalkyl, arylC1-10 alkyl, C9-12 bicyclic aryl, heteroC4-12 bicyclic aryl, carbonylC1-3 alkyl, thiocarbonylC1-3 alkyl, sulfonylC1-3 alkyl, sulfinylC1-3 alkyl, iminoC1-3 alkyl, amino, cyano, C6-C12 aryl, 3-12 membered heteroaryl, hydroxyl, alkoxy, C6-C12 aryloxy, 3-12 membered heteroaryloxy, sulfonyl or sulfinyl.

8. The method for preparing a C, O-spirocyclic aromatic glycoside compound according to claim 1, characterized in that: In the compound 24, Ar is a group selected from the following group: a substituted or unsubstituted C6-C12 aryl group, a substituted or unsubstituted 3-12 membered heterocyclic group; wherein the substitution refers to that one or more hydrogen atoms on the group are replaced by a substituent selected from the following group: cyano, C1-C6 alkyl, C1-C6 alkoxy, halogen, C1-C6 haloalkyl, carbonyl C2-10 alkoxy, carbonyl C7-10 aryloxy, amide C2-10 alkyl, C6-C12 aryl or 3-12 membered heterocyclic group which is unsubstituted or substituted by 1-3 substituents selected from the following group: halogen, unsubstituted or halogenated C1-C6 alkyl, C1-C6 alkoxy.

9. The method for preparing a C, O-spirocyclic aromatic glycoside compound according to claim 1, characterized in that: In the compound 24, Ar is a substituted or unsubstituted group selected from the following group: phenyl, furan, thiophene, pyrrole, pyrazole, triazole, isoxazole, oxazole, thiazole, isothiazole, oxadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, benzofuran, isobenzofuran, benzothiophene, isobenzothiophene, imidazole, benzimidazole, indole, isoindole, quinoline, isoquinoline, cinnoline, quinazoline, naphthyridine, pyridopyridine, quinoxaline, phthalazine or benzothiazole.

10. The method for preparing a C, O-spirocyclic aromatic glycoside compound according to claim 1, characterized in that: In the compound 23, R1 is hydrogen, halogen, or a substituted or unsubstituted group selected from the group consisting of C1-C6 alkyl, C2-C6 alkenyl, C1-C6 alkoxy, C2-C6 alkynyl, C3-C10 cycloalkyl, C3-C10 cycloalkenyl, C2-10 alkoxycarbonyl, C3-12 cycloalkyl, heteroC3-12 cycloalkyl, carbonyl C1-3 alkyl, thiocarbonyl C1-3 alkyl, sulfonyl C1-3 alkyl, sulfinyl C1-3 alkyl, cyano, C6-C12 aryl, 3-12 membered heteroaryl, hydroxy, alkoxy, C6-C12 aryloxy, 3-12 membered heteroaryloxy, imino, sulfonyl or sulfinyl; In the compound 24, Ar is a substituted or unsubstituted group selected from the following group: phenyl, furan, thiophene, pyrrole, pyrazole, triazole, isoxazole, oxazole, thiazole, isothiazole, oxadiazole, pyridine, pyridazine, pyrimidine, benzofuran, isobenzofuran, benzothiophene, isobenzothiophene, imidazole, benzimidazole, indole, isoindole, quinoline, isoquinoline, naphthyridine, pyridopyridine or benzothiazole.